We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
How to Progress Safe and Effective Cell Therapies for Clinical Use!
News

How to Progress Safe and Effective Cell Therapies for Clinical Use!

How to Progress Safe and Effective Cell Therapies for Clinical Use!
News

How to Progress Safe and Effective Cell Therapies for Clinical Use!

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "How to Progress Safe and Effective Cell Therapies for Clinical Use!"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sistemic believe cell characterization is an essential element in progressing safe and effective cell therapies for mainstream clinical use.

They offer unique miRNA analytical services that provide reliable and cost-effective, characterization and QC tools that are applicable to all cell systems.

Toward this end, Dr Vincent O’Brien (Chief Scientific Officer) and Dr Verna McErlane (Director of Commercial Operations, International) will present data supporting the utility of miRNA in the provision of superior cell characterization and QC methods at the forthcoming Stem Cells Europe conference (20-21 July 2011, Edinburgh).

Dr. Vincent O’Brien will present a poster entitled; ‘A novel microRNA-based stem cell characterization and monitoring tool’, and Verna McErlane will join: Marilyn Robertson, SSCN; Aidan Courtney, Roslin Cells; Dr. David Hay, Fibromed; and, Michael Leek, Immunosolv, at the Scottish Stem Cell Network (SSCN) Panel showcase, “Progress to Therapy and Market” on Wednesday 20 July at 5pm.

Advertisement